Bertilimumab (CAT 213, iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11). Bertilimumab has the potential for allergic disorders research[1].
Molecular Weight:
(144.18 kDa)
Purity:
97.01
CAS Number:
[375348-49-5]
Target:
CCR
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted